Although previous observations have demonstrated the function of Tregs in inhibiting anti-tumor CD8+ T cells in HCC [6–9], the underlying cellular and molecular mechanisms concerning the activation of Tregs still remain largely unknown. The gene discussed is CD8A; the disease is neoplasm.